Tag Archives: ADR

[ad_1] Results from a Phase 3 clinical trial, CAPSTONE-2, evaluating Genentech's Balboxavir Marboxil at Roche (OTCQX: RHHBY) in patients at high risk of influenza-related complications have shown therapeutic benefits. The data was …

[ad_1] FDA approves use of Eisai (OTCPK: ESALY + 1.8%) FYCOMPA (perampanel) CIII, alone or in combination with other medicinal products, for the treatment of pediatric patients with partial seizures and at …